MedX Health stock analysis
MedX Health ( ($TSE:MDX) ) just unveiled an announcement. MedX Health Corp. has appointed Monaco‑based skin measurement specialist Monaderm as a key sales agent for its SkinSecure™ platform across Europe,
The latest update is out from MedX Health ( ($TSE:MDX) ). MedX Health Corp., a Canadian medical-technology firm, develops non-invasive skin-screening and teledermatology solutions built around its proprietary SIAscopy imaging
MedX Health ( ($TSE:MDX) ) has provided an announcement. In 2025, MedX Health Corp. invested over CAD$2 million to enhance its technology platform and operational infrastructure, preparing for a large-scale
MedX Health Corp. develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It offers SIAscopy on DermSecure telemedicine platform, which is used to scan skin for suspicious moles and lesions, and phototherapeutic medical devices. Its brands include the DermSecure, MoleMate, SIMSYS, and SIAMETRICS. The company was founded on April 15, 1999 and is headquartered in Mississauga, Canada.
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 3 | 13 |
| Technical Analysis | 5 | 3 | 1 |
| Moving Averages | 0 | 0 | 12 |
